Csenge Advisory Group’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $384K | Sell |
5,269
-759
| -13% | -$55.3K | 0.02% | 491 |
|
|
2025
Q1 | $407K | Buy |
6,028
+2,915
| +94% | +$197K | 0.02% | 447 |
|
|
2024
Q4 | $204K | Sell |
3,113
-446
| -13% | -$29.2K | 0.01% | 664 |
|
|
2024
Q3 | $275K | Buy |
3,559
+565
| +19% | +$43.7K | 0.01% | 583 |
|
|
2024
Q2 | $234K | Buy |
+2,994
| New | +$234K | 0.01% | 586 |
|
|
2023
Q1 | – | Sell |
-4,720
| Closed | -$320K | – | 599 |
|
|
2022
Q4 | $320K | Sell |
4,720
-12
| -0.3% | -$814 | 0.02% | 448 |
|
|
2022
Q3 | $260K | Sell |
4,732
-1,043
| -18% | -$57.3K | 0.02% | 502 |
|
|
2022
Q2 | $382K | Sell |
5,775
-3,466
| -38% | -$229K | 0.03% | 388 |
|
|
2022
Q1 | $613K | Sell |
9,241
-397
| -4% | -$26.3K | 0.05% | 329 |
|
|
2021
Q4 | $581K | Sell |
9,638
-3,690
| -28% | -$222K | 0.05% | 311 |
|
|
2021
Q3 | $795K | Buy |
13,328
+3,690
| +38% | +$220K | 0.07% | 266 |
|
|
2021
Q2 | $581K | Buy |
9,638
+5,008
| +108% | +$302K | 0.05% | 312 |
|
|
2021
Q1 | $231K | Sell |
4,630
-188
| -4% | -$9.38K | 0.02% | 446 |
|
|
2020
Q4 | $241K | Buy |
+4,818
| New | +$241K | 0.03% | 371 |
|
|
2018
Q4 | – | Sell |
-376
| Closed | -$15K | – | 314 |
|
|
2018
Q3 | $15K | Buy |
+376
| New | +$15K | 0.01% | 417 |
|